Ready or Not, Here They Come: A Practical Guide to Adoptive T cell Therapies for Solid Tumors for Medical Oncologists - PubMed
3 hours ago
- #Toxicity management
- #Solid tumors
- #Adoptive cell therapy
- Adoptive cell therapies (ACTs) include CARs, BiTES, TILs, and TCR gene modified T cells.
- ACTs have improved outcomes in hematologic malignancies and show promise in solid tumors.
- Medical oncologists need to manage unique toxicities like CRS and ICANS.
- The review provides clinical data on ACTs in solid tumors and toxicity management.
- Early recognition and evidence-based management of CRS and ICANS are crucial for patient outcomes.